Peter Attia· MD
This might be actually one of the ones where I would say unlike in the rapid trial, you actually want to come up with primary outcomes that are quite different here. This is where uh for example, I'd want to see fat oxidation. Yeah. I'd want to see, you know, what we talk about as zone 2 efficiency. I mean, if this is indeed improving mitochondrial function, I I'm not aware of a better test of mitochondrial function.